chronic condition management

By Jonah Comstock March 20, 2019
Chronic disease management platform Hello Heart will now integrate with LifeScan OneTouch meters as part of its program for diabetes management. The Redwood City, California-based company started out in hypertension, but has been expanding into diabetes for the past year. OneTouch meters, formerly owned by Johnson & Johnson, are the first of a handful of glucometer brands the company intends...
By Jonah Comstock January 30, 2019
Chronic condition management startup Livongo has acquired MyStrength, a Denver-based digital behavioral health company. The company did not disclose the acquisition price, but Livongo CEO Glen Tullman told Babyforyou.net.ua the figure is in the tens of millions. “This entry into behavioral was to complete what we call the whole person platform, and to be able to go to someone and say ‘Whatever...
Dr. Richard Milani
By Jonah Comstock January 2, 2019
Ochsner Health System in New Orleans has been using mobile technology to monitor and manage chronic disease patients since 2015. In that time, the doctors behind the program have learned a lot about how to implement such a system, as well as about how effective it can be. “We’ve learned a lot,” said Dr. Richard Milani, Ochsner's chief clinical transformation officer and medical director of...
By Jonah Comstock April 11, 2018
Digital chronic disease management company Livongo has raised $105 million in new Series E funding, mostly from existing investors. The company also announced a partnership with nonprofit health insurance company Cambia Health Solutions. General Catalyst and Swedish investment company Kinnevik led the round, with additional participation from existing investors DFJ, Kleiner Perkins Caufield...
By Jonah Comstock February 12, 2018
Correction: A previous version of this article misstated Provata's 2016 revenue. Merck subsidiary StayWell, which offers a preventative health platform for employers, health plans, and health systems, has acquired Provata Health for an undisclosed sum. Provata Health makes a digital health platform for employee wellness, which includes a chronic disease management program incorporating a...
By Jonah Comstock January 23, 2018
Mount Sinai Health System is trying a new way to get high-risk patients to take their medications: financial incentives. Supported by a grant from Health 2.0 and the New York City Economic Development Corporation, the New York health system has enrolled 12 patients in a pilot with startup Wellth. “What I’m so impressed with is a lot of companies go out and say ‘We want to make this and this is...
By Jonah Comstock December 27, 2017
Digital health in pharma definitely had a milestone moment in the fourth quarter with the FDA approval of Abilify MyCite, a new, sensor-enabled version of Otsuka’s drug for schizophrenia powered by Proteus Digital Health’s ingestible sensor technology. In addition to that, the quarter saw numerous other moves by pharma companies around clinical trials, chronic disease management, mental health,...
By Heather Mack February 16, 2017
Chronic disease management company Livongo is collaborating with Voluntis, the Paris, France-based company that develops companion apps for medical devices, to offer an integrated program, insulin delivery system and app for people with type 2 diabetes. Members will have access to the Livongo for Diabetes Program with Voluntis’ Insulia, the diabetes management app that received both FDA approval...
By Heather Mack January 5, 2017
Online network PatientsLikeMe, which serves as an information, support and study recruitment source for people living with chronic conditions, has secured $100 million in new funding, largely from a new partnership with health data and genomics company iCarbonX. Existing investor Invus also contributed to the funding round, which is still open. “This partnership is very exciting, as it...
By Jonah Comstock May 18, 2016
Teladoc plans to launch its first chronic condition management program by the end of the year, CEO Jason Gorevic revealed at a session toward the end of the American Telemedicine Association convention in Minneapolis.  “We’re still in the final stages of deciding whether it’s going to be cardiovascular disease or diabetes,” he said. “It’s a tremendous opportunity for more longitudinal care....
Мы предлагаем заказать и https://danabol-in.com недорого с доставкой.
http://ka4alka-ua.com

Наш нужный сайт со статьями про Болденон болденон